Vaxil Bio Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was CAD 0.028 million compared to CAD 0.139 million a year ago.
For the nine months, net loss was CAD 0.28 million compared to CAD 0.411 million a year ago.